PPD Inc (PPD) Stock
PPD is no longer traded. PPD was acquired by Thermo Fisher (TMO) on December 8, 2021.
Each PPD share was exchanged for $47.50 in cash. Prices on this page are historical; the last trade was December 7, 2021 at $47.28.
See Thermo Fisher (TMO) stock →PPD stock price history
PPD final trading statistics
- Final close
- $47.28
- Final trading day
- Dec 7, 2021
- Market cap at delisting
- $16.61B
- Shares outstanding
- 351.40M
- Final 52-week range
- $31.54 – $47.41
- Avg. volume (final 3 mo.)
- 1,713,259
- All-time high (split-adj.)
- $47.41 · Nov 2021
- All-time low (split-adj.)
- $14.00 · Mar 2020
- Return since IPO
- +57.6%
- Beta
- —
- Book value / share
- —
- Price / book
- —
PPD annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2020 | $4.68B | $153.7M | $1.18 |
| FY2019 | $4.03B | $47.8M | $5.46 |
| FY2018 | $3.75B | $104.2M | — |
| FY2017 | $3.00B | $296.0M | — |
| FY2016 | $2.68B | $183.1M | — |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About PPD Inc
PPD, Inc., together with its subsidiaries, provides drug development services to the biopharmaceutical industry worldwide. The company operates through two segments, Clinical Development Services and Laboratory Services. It offers clinical development services, including product development and consulting, early development, Phases II-IV clinical trial management, accelerated enrollment, peri-and post-approval, and medical communications services. The company also provides laboratory services comprising bioanalytical, biomarker, vaccine science, good manufacturing practice, and central laboratory services. It serves pharmaceutical, biotechnology, medical device, and government organizations, as well as other industry participants. The company has a collaboration with Science 37 to design, build, test, implement, and execute digital trials using Science 37's DCT SaaS-based technology platform. PPD, Inc. was founded in 1985 and is headquartered in Wilmington, North Carolina. As of December 8, 2021, PPD, Inc. operates as a subsidiary of Thermo Fisher Scientific Inc.
PPD stock FAQ
What happened to PPD stock?
PPD was acquired by Thermo Fisher (TMO) on December 8, 2021. Shareholders received $47.50 in cash for each share. PPD stock stopped trading on the Nasdaq, with a final close of $47.28 on December 7, 2021.
What did PPD shareholders receive?
Each PPD share was converted into $47.50 in cash. The deal was valued at about $17.4 billion.
Is PPD stock still trading?
No. PPD was delisted from the Nasdaq on December 8, 2021 and no longer trades on a U.S. exchange.
What was the last price of PPD stock?
PPD closed at $47.28 on its final trading day, December 7, 2021, for a market value of about $16.61B.
What were PPD's revenue and earnings in its last full fiscal year?
PPD reported revenue of $4.68B and net income of $153.7M in fiscal 2020, its last full year as a public company.
When did PPD go public?
PPD Inc stock began trading on February 6, 2020.